A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

NCT04703322 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Tenosynovial Giant Cell Tumor

Interventions

DRUG: Pexidartinib

Sponsor

Daiichi Sankyo Co., Ltd.